Millrace Asset Group Inc. Has $1.70 Million Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Millrace Asset Group Inc. raised its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 13.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 231,322 shares of the company’s stock after purchasing an additional 27,084 shares during the period. Viemed Healthcare accounts for approximately 1.7% of Millrace Asset Group Inc.’s holdings, making the stock its 24th biggest holding. Millrace Asset Group Inc. owned about 0.59% of Viemed Healthcare worth $1,696,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Evernest Financial Advisors LLC bought a new position in Viemed Healthcare during the second quarter worth about $66,000. Perkins Coie Trust Co acquired a new stake in shares of Viemed Healthcare in the 3rd quarter valued at approximately $73,000. Price T Rowe Associates Inc. MD acquired a new position in Viemed Healthcare during the first quarter valued at approximately $97,000. SG Americas Securities LLC acquired a new position in Viemed Healthcare during the third quarter valued at approximately $89,000. Finally, Victory Capital Management Inc. increased its stake in Viemed Healthcare by 21.1% in the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock valued at $84,000 after purchasing an additional 2,226 shares in the last quarter. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Viemed Healthcare

In other news, Director Nitin Kaushal sold 30,000 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the transaction, the director now owns 126,843 shares in the company, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now directly owns 107,706 shares of the company’s stock, valued at $999,511.68. This trade represents a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 20.00% of the company’s stock.

Viemed Healthcare Stock Performance

VMD stock opened at $8.65 on Tuesday. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The firm has a market cap of $336.83 million, a PE ratio of 32.04 and a beta of 1.43. The business’s 50-day moving average price is $8.51 and its two-hundred day moving average price is $7.57.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $58.00 million for the quarter.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.